<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02881658</url>
  </required_header>
  <id_info>
    <org_study_id>CTC1521</org_study_id>
    <nct_id>NCT02881658</nct_id>
  </id_info>
  <brief_title>The Effect of 3-Week Consumption of Soya Beverage Enriched With Plant Sterols on Serum LDL-C</brief_title>
  <official_title>The Effect of Soya Beverage Fortified With Plant Sterol on Major Serum Lipids in Normocholesterolemic, Healthy Southern Chinese Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Hong Kong</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a local, single-center, two-arm, randomized, double-blind, placebo-controlled
      clinical trial that examines the LDL-C-lowering effect of the consumption of a soya beverage
      enriched with plant sterol for 3 weeks. This study also examines if there is other
      health-benefits by consuming the plant sterols fortified soya beverage in terms of serum
      total triglyceride, total and HDL cholesterol, other cardiometabolic risk factors and
      musculoskeletal-related traits including handgrip strength, gait speed, peak expiratory flow
      rate, bio-impedance and body balance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiovascular disease (CVD) is the third commonest cause of deaths in Hong Kong and
      accounting for 14.4% of all deaths in 2012. Robust data attest the causal role of low-density
      lipoprotein cholesterol (LDL-C) in the development and progression of CVD. Reduction of LDL-C
      levels achieved by pharmacological agents in conjunction with diet change has been
      demonstrated to significantly reduce CVD morbidity and mortality. Moreover, it has been
      frequently reported that dietary incorporation of plant sterols/stanols could reduce blood
      LDL-C level in both healthy and dyslipidaemic individuals with great inter-individual
      variability of LDL-C response. Therefore, functional food enriched with plant sterols/stanols
      not only may provide additional LDL-C lowering benefit in dyslipidaemic patients as an
      adjunct to traditional pharmacologic therapy, but also play a role in primary prevention of
      CVD in the general population.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Actual">February 1, 2017</completion_date>
  <primary_completion_date type="Actual">February 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean of Serum Low-density Lipoprotein Cholesterol (LDL-C) Via Blood Test at Baseline and Week 3</measure>
    <time_frame>From baseline to week 3</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of Low Density Lipoprotein Cholesterol (LDL-C) Via Blood Test at Baseline and Week 3</measure>
    <time_frame>From baseline to week 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of High-density Lipoprotein Cholesterol (HDL-C) Via Blood Test at Baseline and Week 3</measure>
    <time_frame>From baseline to week 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Total Cholesterol Via Blood Test at Baseline and Week 3</measure>
    <time_frame>From baseline to week 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Triglycerides (TAG) Via Blood Test at Baseline and Week 3</measure>
    <time_frame>From baseline to week 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Serum Creatinine Via Blood Test at Baseline and Week 3</measure>
    <time_frame>From baseline to week 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of Fasting Blood Glucose Via Blood Test at Baseline and Week 3</measure>
    <time_frame>From baseline to week 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of Cardiometabolic Risk Factors Via Measuring Anthropometry at Baseline and Week 3</measure>
    <time_frame>From baseline to week 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of Cardiometabolic Risk Factors Via Measuring Blood Pressure at Baseline and Week 3</measure>
    <time_frame>From baseline to week 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of Cardiometabolic Risk Factors Via Measuring Body Temperature at Baseline and Week 3</measure>
    <time_frame>From baseline to week 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of Musculoskeletal-related Traits Via Measuring Hand Grip Strength at Baseline and Week 3</measure>
    <time_frame>From baseline to week 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of Musculoskeletal-related Traits Via Measuring Bio-Impedance at Baseline and Week 3</measure>
    <time_frame>From baseline to week 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of Musculoskeletal-related Traits Via Measuring Peak Expiratory Flow Rate at Baseline and Week 3</measure>
    <time_frame>From baseline to week 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of Musculoskeletal-related Traits Via Measuring 6 Metres Gait Speed at Baseline and Week 3</measure>
    <time_frame>From baseline to week 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of Musculoskeletal-related Traits Via Measuring Centre of Pressure Excursion Index for Left and Right Foot at Baseline and Week 3</measure>
    <time_frame>From baseline to week 3</time_frame>
    <description>centre of pressure excursion index = CPEI</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">201</enrollment>
  <condition>Dyslipidemia</condition>
  <arm_group>
    <arm_group_label>Plant sterols-enriched soya beverage provided by Vitasoy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Soya beverage provided by Vitasoy</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Daily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Plant sterols-enriched soya beverage provided by Vitasoy</intervention_name>
    <description>the study product is a 2g plant sterols-enriched in 250ml soya beverage</description>
    <arm_group_label>Plant sterols-enriched soya beverage provided by Vitasoy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Soya beverage provided by Vitasoy</intervention_name>
    <description>the placebo product is a 250 ml soya beverage</description>
    <arm_group_label>Soya beverage provided by Vitasoy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Southern Chinese male or female â‰¥ 18 years;

          -  In good general health as evidenced by medical history;

          -  Have the ability to understand the requirements of the study, provide written informed
             consent, including consent for the use and disclose of research-related health
             information, and comply with the study data collection procedures. Provide signed and
             dated informed consent form

        Exclusion Criteria:

          -  Subject with familial hypercholesterolemia;

          -  On regular medication(s) which affect gastrointestinal functions and blood lipids
             level for the past 3 months, such as, but not limited to:

               -  Antibiotics of &gt;1 week duration

               -  GI related medications such as antacids

          -  Having blood lipid lowering medications such as statins, selective cholesterol
             absorption inhibitors (e.g. ezetimibe), fibrates, niacin, resins, omega- 3

          -  Heavy-smokers (more than 1 pack per day)

          -  Subject with heavy alcohol intake (&gt;40 g/day for men ; &gt;30 g/day for women) (32), or
             having history of alcohol abuse within 12 months prior to the study

          -  Subjects with taste aversion to placebo/intervention soya beverages

          -  Subject refusing to stop the consumption of plant sterols-enriched products if any
             during the study (other than the studied product) or having regular consumption of
             sterols/stanols cholesterol-lowering supplements/functional foods or other related
             products such as:

               -  Sterol/ Stanol - containing margarines, milk, yoghurt drink and soya beverages

               -  Sterol / Stanol supplements

               -  Fish oils &amp; omega-3 supplements

          -  Subject receiving systemic treatment or topical treatment likely to interfere with
             evaluation of the study parameters

          -  Subject currently involved in a clinical trial or in an exclusion period following
             participation in another clinical trial

          -  Pregnancy or lactation

          -  Having soy allergy

          -  Being a vegan

          -  Being an athlete

          -  Concurrently participating in weight management or dietary program

          -  On diet pills, such as, but not limited to chitosan and dulcolax

          -  With history of sitosterolemia

          -  Having history of hypercholesterolemia, diabetes, thyroid disease, severe kidney
             diseases, cardiovascular diseases, chronic gastrointestinal disorders, cancers and
             AIDs ( acquired immune deficiency syndrome)

          -  Having history of malabsorption syndrome arising from diseases such as, but not
             limited to celiac disease, short bowel syndrome, cystic fibrosis, pancreatitis,
             diseases of gall-bladder, liver or pancreas, intestinal infection, injury, surgery and
             radiotherapy

          -  Taking over-the-counter Chinese medications or supplements with cholesterol/lipid
             lowering and related claims

          -  High blood cholesterol at screening [Total cholesterol level â‰¥6.22mmol/L]

          -  High LDL cholesterol [LDL cholesterol level â‰¥4.15mmol/L]

          -  High blood triglyceride at screening [Triglyceride â‰¥3.39mmol/L]

          -  Anything that would place the individual at increased risk or preclude the
             individual's full compliance with or completion of the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernard Man Yung Cheung</last_name>
    <role>Principal Investigator</role>
    <affiliation>Li Ka Shing Faculty of Medicine, The University of Hong Kong</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 14, 2016</study_first_submitted>
  <study_first_submitted_qc>August 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 29, 2016</study_first_posted>
  <results_first_submitted>May 20, 2017</results_first_submitted>
  <results_first_submitted_qc>August 24, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">September 21, 2017</results_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Professor Bernard Cheung</investigator_full_name>
    <investigator_title>Professor of Department of Medicine, HKU</investigator_title>
  </responsible_party>
  <keyword>Plant sterols</keyword>
  <keyword>Low-Density Lipoprotein Cholesterol</keyword>
  <keyword>Phytosterols</keyword>
  <keyword>Soya Beverage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Plant Sterols-enriched Soya Beverage Provided by Vitasoy</title>
          <description>Daily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Plant sterols-enriched soya beverage: the study product is a 2g plant sterols-enriched in 250ml soya beverage</description>
        </group>
        <group group_id="P2">
          <title>Soya Beverage Provided by Vitasoy</title>
          <description>Daily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Soya beverage: the placebo product is a 250 ml soya beverage</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="100"/>
                <participants group_id="P2" count="101"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="98"/>
                <participants group_id="P2" count="96"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Plant Sterols-enriched Soya Beverage Provided by Vitasoy</title>
          <description>Daily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Plant sterols-enriched soya beverage: the study product is a 2g plant sterols-enriched in 250ml soya beverage</description>
        </group>
        <group group_id="B2">
          <title>Soya Beverage Provided by Vitasoy</title>
          <description>Daily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Soya beverage: the placebo product is a 250 ml soya beverage</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="100"/>
            <count group_id="B2" value="101"/>
            <count group_id="B3" value="201"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="100"/>
                    <count group_id="B2" value="101"/>
                    <count group_id="B3" value="201"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46" spread="16.5"/>
                    <measurement group_id="B2" value="44" spread="16.7"/>
                    <measurement group_id="B3" value="45" spread="16.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="100"/>
                    <count group_id="B2" value="101"/>
                    <count group_id="B3" value="201"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="52"/>
                    <measurement group_id="B3" value="101"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean of Serum Low-density Lipoprotein Cholesterol (LDL-C) Via Blood Test at Baseline and Week 3</title>
        <time_frame>From baseline to week 3</time_frame>
        <population>All 201 subjects were included in the population, but certain blood test result on LDL-C were not available, thus difference in the overall number of participants analyzed and the actual number of participants included to present the mean value.</population>
        <group_list>
          <group group_id="O1">
            <title>Plant Sterols-enriched Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Plant sterols-enriched soya beverage: the study product is a 2g plant sterols-enriched in 250ml soya beverage</description>
          </group>
          <group group_id="O2">
            <title>Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Soya beverage: the placebo product is a 250 ml soya beverage</description>
          </group>
        </group_list>
        <measure>
          <title>Mean of Serum Low-density Lipoprotein Cholesterol (LDL-C) Via Blood Test at Baseline and Week 3</title>
          <population>All 201 subjects were included in the population, but certain blood test result on LDL-C were not available, thus difference in the overall number of participants analyzed and the actual number of participants included to present the mean value.</population>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
                <count group_id="O2" value="101"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="93"/>
                    <count group_id="O2" value="93"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.91" spread="0.961"/>
                    <measurement group_id="O2" value="2.83" spread="0.814"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="96"/>
                    <count group_id="O2" value="95"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.71" spread="0.830"/>
                    <measurement group_id="O2" value="2.75" spread="0.794"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change of Low Density Lipoprotein Cholesterol (LDL-C) Via Blood Test at Baseline and Week 3</title>
        <time_frame>From baseline to week 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plant Sterols-enriched Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).</description>
          </group>
          <group group_id="O2">
            <title>Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).</description>
          </group>
        </group_list>
        <measure>
          <title>Change of Low Density Lipoprotein Cholesterol (LDL-C) Via Blood Test at Baseline and Week 3</title>
          <units>percentage of change</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="91"/>
                <count group_id="O2" value="88"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.69" lower_limit="-15.36" upper_limit="2.19"/>
                    <measurement group_id="O2" value="-1.56" lower_limit="-10.22" upper_limit="7.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change of High-density Lipoprotein Cholesterol (HDL-C) Via Blood Test at Baseline and Week 3</title>
        <time_frame>From baseline to week 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plant Sterols-enriched Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).</description>
          </group>
          <group group_id="O2">
            <title>Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).</description>
          </group>
        </group_list>
        <measure>
          <title>Change of High-density Lipoprotein Cholesterol (HDL-C) Via Blood Test at Baseline and Week 3</title>
          <units>percentage of change</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="97"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" lower_limit="-5.56" upper_limit="7.69"/>
                    <measurement group_id="O2" value="0.0" lower_limit="-6.67" upper_limit="11.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change of Total Cholesterol Via Blood Test at Baseline and Week 3</title>
        <time_frame>From baseline to week 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plant Sterols-enriched Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Plant sterols-enriched soya beverage: the study product is a 2g plant sterols-enriched in 250ml soya beverage</description>
          </group>
          <group group_id="O2">
            <title>Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Soya beverage: the placebo product is a 250 ml soya beverage</description>
          </group>
        </group_list>
        <measure>
          <title>Change of Total Cholesterol Via Blood Test at Baseline and Week 3</title>
          <units>percentage of change</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="97"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.82" lower_limit="-8.38" upper_limit="3.16"/>
                    <measurement group_id="O2" value="-1.86" lower_limit="-7.06" upper_limit="4.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change of Triglycerides (TAG) Via Blood Test at Baseline and Week 3</title>
        <time_frame>From baseline to week 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plant Sterols-enriched Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Plant sterols-enriched soya beverage: the study product is a 2g plant sterols-enriched in 250ml soya beverage</description>
          </group>
          <group group_id="O2">
            <title>Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Soya beverage: the placebo product is a 250 ml soya beverage</description>
          </group>
        </group_list>
        <measure>
          <title>Change of Triglycerides (TAG) Via Blood Test at Baseline and Week 3</title>
          <units>percentage of change</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="97"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" lower_limit="-18.64" upper_limit="21.15"/>
                    <measurement group_id="O2" value="-1.88" lower_limit="-17.21" upper_limit="19.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change of Serum Creatinine Via Blood Test at Baseline and Week 3</title>
        <time_frame>From baseline to week 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plant Sterols-enriched Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Plant sterols-enriched soya beverage: the study product is a 2g plant sterols-enriched in 250ml soya beverage</description>
          </group>
          <group group_id="O2">
            <title>Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Soya beverage: the placebo product is a 250 ml soya beverage</description>
          </group>
        </group_list>
        <measure>
          <title>Change of Serum Creatinine Via Blood Test at Baseline and Week 3</title>
          <units>percentage of change</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="97"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="-4" upper_limit="6"/>
                    <measurement group_id="O2" value="0" lower_limit="-4" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes of Fasting Blood Glucose Via Blood Test at Baseline and Week 3</title>
        <time_frame>From baseline to week 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plant Sterols-enriched Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Plant sterols-enriched soya beverage: the study product is a 2g plant sterols-enriched in 250ml soya beverage</description>
          </group>
          <group group_id="O2">
            <title>Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Soya beverage: the placebo product is a 250 ml soya beverage</description>
          </group>
        </group_list>
        <measure>
          <title>Changes of Fasting Blood Glucose Via Blood Test at Baseline and Week 3</title>
          <units>percentage of change</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="97"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" lower_limit="-4.3" upper_limit="4.1"/>
                    <measurement group_id="O2" value="0.0" lower_limit="-4.2" upper_limit="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes of Cardiometabolic Risk Factors Via Measuring Anthropometry at Baseline and Week 3</title>
        <time_frame>From baseline to week 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plant Sterols-enriched Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Plant sterols-enriched soya beverage: the study product is a 2g plant sterols-enriched in 250ml soya beverage</description>
          </group>
          <group group_id="O2">
            <title>Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Soya beverage: the placebo product is a 250 ml soya beverage</description>
          </group>
        </group_list>
        <measure>
          <title>Changes of Cardiometabolic Risk Factors Via Measuring Anthropometry at Baseline and Week 3</title>
          <units>percentage of change</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="98"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Median percentage change of Body weight</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" lower_limit="-0.8" upper_limit="0.9"/>
                    <measurement group_id="O2" value="0.2" lower_limit="-0.6" upper_limit="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Median percentage change of Waist circumference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="-2" upper_limit="3"/>
                    <measurement group_id="O2" value="0" lower_limit="-3" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Median percentage change of Hip circumference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="-1" upper_limit="1"/>
                    <measurement group_id="O2" value="0" lower_limit="-1" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes of Cardiometabolic Risk Factors Via Measuring Blood Pressure at Baseline and Week 3</title>
        <time_frame>From baseline to week 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plant Sterols-enriched Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Plant sterols-enriched soya beverage: the study product is a 2g plant sterols-enriched in 250ml soya beverage</description>
          </group>
          <group group_id="O2">
            <title>Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Soya beverage: the placebo product is a 250 ml soya beverage</description>
          </group>
        </group_list>
        <measure>
          <title>Changes of Cardiometabolic Risk Factors Via Measuring Blood Pressure at Baseline and Week 3</title>
          <units>percentage of change</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="98"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Median percentage change of Sys. blood pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1" lower_limit="-6" upper_limit="2"/>
                    <measurement group_id="O2" value="-2" lower_limit="-5" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Median percentage change of Dia. blood pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3" lower_limit="-7" upper_limit="1"/>
                    <measurement group_id="O2" value="-3" lower_limit="-6" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes of Cardiometabolic Risk Factors Via Measuring Body Temperature at Baseline and Week 3</title>
        <time_frame>From baseline to week 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plant Sterols-enriched Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Plant sterols-enriched soya beverage: the study product is a 2g plant sterols-enriched in 250ml soya beverage</description>
          </group>
          <group group_id="O2">
            <title>Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Soya beverage: the placebo product is a 250 ml soya beverage</description>
          </group>
        </group_list>
        <measure>
          <title>Changes of Cardiometabolic Risk Factors Via Measuring Body Temperature at Baseline and Week 3</title>
          <units>percentage of body temperature change</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="98"/>
                <count group_id="O2" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" lower_limit="-0.5" upper_limit="0.0"/>
                    <measurement group_id="O2" value="-0.3" lower_limit="-0.5" upper_limit="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes of Musculoskeletal-related Traits Via Measuring Hand Grip Strength at Baseline and Week 3</title>
        <time_frame>From baseline to week 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plant Sterols-enriched Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Plant sterols-enriched soya beverage: the study product is a 2g plant sterols-enriched in 250ml soya beverage</description>
          </group>
          <group group_id="O2">
            <title>Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Soya beverage: the placebo product is a 250 ml soya beverage</description>
          </group>
        </group_list>
        <measure>
          <title>Changes of Musculoskeletal-related Traits Via Measuring Hand Grip Strength at Baseline and Week 3</title>
          <units>percentage of change</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="92"/>
                <count group_id="O2" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="-8" upper_limit="11"/>
                    <measurement group_id="O2" value="0" lower_limit="-12" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes of Musculoskeletal-related Traits Via Measuring Bio-Impedance at Baseline and Week 3</title>
        <time_frame>From baseline to week 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plant Sterols-enriched Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Plant sterols-enriched soya beverage: the study product is a 2g plant sterols-enriched in 250ml soya beverage</description>
          </group>
          <group group_id="O2">
            <title>Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Soya beverage: the placebo product is a 250 ml soya beverage</description>
          </group>
        </group_list>
        <measure>
          <title>Changes of Musculoskeletal-related Traits Via Measuring Bio-Impedance at Baseline and Week 3</title>
          <units>percentage of change</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="97"/>
                <count group_id="O2" value="93"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Median % change of Bioimpedance - Fat percentage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.0" lower_limit="-4.1" upper_limit="1.8"/>
                    <measurement group_id="O2" value="-0.8" lower_limit="-3.6" upper_limit="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Median % change of Bioimpedance - Fat mass</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.1" lower_limit="-4.8" upper_limit="2.1"/>
                    <measurement group_id="O2" value="-0.7" lower_limit="-3.3" upper_limit="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes of Musculoskeletal-related Traits Via Measuring Peak Expiratory Flow Rate at Baseline and Week 3</title>
        <time_frame>From baseline to week 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plant Sterols-enriched Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Plant sterols-enriched soya beverage: the study product is a 2g plant sterols-enriched in 250ml soya beverage</description>
          </group>
          <group group_id="O2">
            <title>Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Soya beverage: the placebo product is a 250 ml soya beverage</description>
          </group>
        </group_list>
        <measure>
          <title>Changes of Musculoskeletal-related Traits Via Measuring Peak Expiratory Flow Rate at Baseline and Week 3</title>
          <units>percentage of change</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="98"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="-5" upper_limit="7"/>
                    <measurement group_id="O2" value="-0" lower_limit="-5" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes of Musculoskeletal-related Traits Via Measuring 6 Metres Gait Speed at Baseline and Week 3</title>
        <time_frame>From baseline to week 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plant Sterols-enriched Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Plant sterols-enriched soya beverage: the study product is a 2g plant sterols-enriched in 250ml soya beverage</description>
          </group>
          <group group_id="O2">
            <title>Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Soya beverage: the placebo product is a 250 ml soya beverage</description>
          </group>
        </group_list>
        <measure>
          <title>Changes of Musculoskeletal-related Traits Via Measuring 6 Metres Gait Speed at Baseline and Week 3</title>
          <units>percentage of change</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="98"/>
                <count group_id="O2" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.74" lower_limit="-7.80" upper_limit="6.81"/>
                    <measurement group_id="O2" value="-1.46" lower_limit="-8.41" upper_limit="9.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes of Musculoskeletal-related Traits Via Measuring Centre of Pressure Excursion Index for Left and Right Foot at Baseline and Week 3</title>
        <description>centre of pressure excursion index = CPEI</description>
        <time_frame>From baseline to week 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plant Sterols-enriched Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Plant sterols-enriched soya beverage: the study product is a 2g plant sterols-enriched in 250ml soya beverage</description>
          </group>
          <group group_id="O2">
            <title>Soya Beverage Provided by Vitasoy</title>
            <description>Daily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Soya beverage: the placebo product is a 250 ml soya beverage</description>
          </group>
        </group_list>
        <measure>
          <title>Changes of Musculoskeletal-related Traits Via Measuring Centre of Pressure Excursion Index for Left and Right Foot at Baseline and Week 3</title>
          <description>centre of pressure excursion index = CPEI</description>
          <units>Percentage of Change</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="96"/>
                <count group_id="O2" value="92"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Median percentage of CPEI change (left foot)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="-22" upper_limit="26"/>
                    <measurement group_id="O2" value="0" lower_limit="-21" upper_limit="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Median percentage of CPEI change (right foot)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="-17" upper_limit="22"/>
                    <measurement group_id="O2" value="-5" lower_limit="-20" upper_limit="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Participants were asked to complete a questionnaire related to adverse event that happened during the 3 weeks period of consuming soya beverage.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Plant Sterols-enriched Soya Beverage</title>
          <description>Daily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Plant sterols-enriched soya beverage: the study product is a 2g plant sterols-enriched in 250ml soya beverage</description>
        </group>
        <group group_id="E2">
          <title>Soya Beverage</title>
          <description>Daily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Soya beverage: the placebo product is a 250 ml soya beverage</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="101"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="100"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="100"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="101"/>
              </event>
              <event>
                <sub_title>Stomach Bloating</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="101"/>
              </event>
              <event>
                <sub_title>Slight hardening of stool during the three weeks period</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="100"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Flu</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="100"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Cheung Ching Lung</name_or_title>
      <organization>The University of Hong Kong</organization>
      <phone>(852)28315085</phone>
      <email>lung1212@hku.hk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

